Advertisement

World Journal of Pediatrics

, Volume 12, Issue 4, pp 498–500 | Cite as

Complete resection of a huge hypervascular inflammatory myofibroblastic tumor in right hemithorax after embolization

  • Kyu-Nam Kim
  • Dong-Won KimEmail author
Case report

Abstract

Background

Inflammatory myofibroblastic tumor (IMT) is a rare and mostly benign tumor that has the possibility of malignant change.

Methods

Radiological findings revealed a huge mass that filled most of the right hemithorax of a 17-monthold female infant. Tumor extirpation was stopped due to massive bleeding and limited exposure of the tumor. Embolization was conducted to obstruct the arteries feeding the mass. Complete resection was performed.

Results

Histopathologic examination led to the diagnosis of IMT. Postoperative recovery was uneventful.

Conclusion

Hypervascularity of IMT should be considered. Preoperative embolization can be effective to reduce intraoperative blood loss and facilitate the surgical procedure.

Keywords

embolization granuloma mediastinal neoplasms plasma cell 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cerfolio RJ, Allen MS, Nascimento AG, Deschamps C, Trastek VF, Miller DL, et al. Inflammatory pseudotumors of the lung. Ann Thorac Surg 1999;67:933–936.CrossRefPubMedGoogle Scholar
  2. 2.
    Melloni G, Carretta A, Ciriaco P, Arrigoni G, Fieschi S, Rizzo N, et al. Inflammatory pseudotumor of the lung in adults. Ann Thorac Surg 2005;79:426–432.CrossRefPubMedGoogle Scholar
  3. 3.
    Berman M, Georghiou GP, Schonfeld T, Feinmesser M, Horev G, Vidne BA, et al. Pulmonary inflammatory myofibroblastic tumor invading the left atrium. Ann Thorac Surg 2003;76:601–603.CrossRefPubMedGoogle Scholar
  4. 4.
    Donner LR, Trompler RA, White RR. Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences. Hum Pathol 1996;27:1095–1098.CrossRefPubMedGoogle Scholar
  5. 5.
    Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, Ettinghausen SE, Madeb R, et al. Inflammatory myofibroblastic tumors. J Surg Oncol 2006;94:385–391.CrossRefPubMedGoogle Scholar
  6. 6.
    Karnak I, Senocak ME, Ciftci AO, Caglar M, Bingöl- Kologlu M, Tanyel FC, et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg 2001;36:908–912.CrossRefPubMedGoogle Scholar
  7. 7.
    Lau V, Sun M, Chu F. Embolisation of hypervascular bone tumours: a pictorial essay with literature review. J Med Imaging Radiat Oncol 2013;57:191–197.CrossRefPubMedGoogle Scholar
  8. 8.
    Diop B, Konate I, Ka S, Sall I, Fall D, Dieng M, et al. Mesenteric myofibroblastic tumor: NSAID therapy after incomplete resection. J Visc Surg 2011;148:e311–e314.CrossRefGoogle Scholar
  9. 9.
    Chun YS, Wang L, Nascimento AG, Moir CR, Rodeberg DA. Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis. Pediatr Blood Cancer 2005;45:796–801.CrossRefPubMedGoogle Scholar
  10. 10.
    Applebaum H, Kieran MW, Cripe TP, Coffin CM, Collins MH, Kaipainen A, et al. The rationale for nonsteroidal anti inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children’s Onology Group study. J Pediatr Surg 2005;40:999–1003; discussion 1003.CrossRefPubMedGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine and Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Department of Anesthesiology and Pain MedicineHanyang University HospitalSeoulRepublic of Korea

Personalised recommendations